From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
Intermediate-risk (PSA 10–20 ng/mL or ISUP 2 and 3) | High-risk (PSA > 20 ng/mL or ISUP 4 and 5) | p-value | |
---|---|---|---|
n = 71 | n = 118 | ||
SUVmax of primary tumoura | 11.9 (8.4–21.1) | 20.2 (12.0–32.5) | < 0.001 |
Nodal metastasis(regional and non-regional)b | 1.4% (1) | 34.7% (41) | < 0.001 |
Bone metastasisb | 8.5% (6) | 28.0% (33) | 0.001 |
Visceral metastasisc | 2.8% (2) | 4.2% (5) | 0.71 |